← Eichor
Study identifier: NCT02061306 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Condition: Celiac Disease  ·  Sponsor: Massachusetts General Hospital

PhaseN/A
Planned participants500
Who can joinAll sexes, N/A to 6 Months
Healthy volunteersNo

About this study

Celiac disease (CD) is a complex disease caused by eating gluten, a protein contained in wheat, rye, and barley. It is well known that many factors contribute to the development of CD, including the genes that you have and the foods that you eat. In the CDGEMM study, we will consider as many of these factors as possible and study how they each contribute to disease development. If the investigators find that any one factor, or combination of factors, increases the risk of developing CD, we will be able to apply this information and help prevent or detect disease in high-risk children in the future.

This description comes directly from the study's public registry record.

Talk to the study team

Victoria Kenyon, MHA  ·  617-643-4366  ·  vakenyon@mgb.org

Always discuss trial participation with your own doctor first.

Locations (2)

MassGeneral Hospital for ChildrenBoston, Massachusetts, United StatesRecruiting
University of Roma La SapienzaRome, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02061306